{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:29:14Z","timestamp":1791048554779,"version":"4.1.0"},"reference-count":7,"publisher":"American Physiological Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Physiology-Endocrinology and Metabolism"],"published-print":{"date-parts":[[1999,11,1]]},"abstract":"<jats:p>\n                    Peptides purified by HPLC are often in the form of a trifluoroacetate (TFA) salt, because trifluoroacetic acid is used as a solvent in reversed-phase HPLC separation. However, the potential effects of this contaminant in culture systems have not been addressed previously. TFA (10\n                    <jats:sup>\u22128<\/jats:sup>\n                    to 10\n                    <jats:sup>\u22127<\/jats:sup>\n                    M) reduced cell numbers and thymidine incorporation into fetal rat osteoblast cultures after 24 h. Similar effects were found in cultures of articular chondrocytes and neonatal mouse calvariae, indicating that the effect is not specific to one cell type or to one species of origin. When the activities of the TFA and hydrochloride salts of amylin, amylin-(1\u20148), and calcitonin were compared in osteoblasts, cell proliferation was consistently less with the TFA salts of these peptides, resulting in failure to detect a proliferative effect or wrongly attributing an antiproliferative effect. This finding is likely to be relevant to all studies of purified peptides in concentrations above 10\n                    <jats:sup>\u22129<\/jats:sup>\n                    M in whatever cell or tissue type. Such peptides should be converted to a hydrochloride or biologically equivalent salt before assessment of their biological effects is undertaken.\n                  <\/jats:p>","DOI":"10.1152\/ajpendo.1999.277.5.e779","type":"journal-article","created":{"date-parts":[[2017,12,22]],"date-time":"2017-12-22T01:58:07Z","timestamp":1513907887000},"page":"E779-E783","source":"Crossref","is-referenced-by-count":64,"title":["Trifluoroacetate, a contaminant in purified proteins,  inhibits proliferation of osteoblasts and chondrocytes"],"prefix":"10.1152","volume":"277","author":[{"given":"J.","family":"Cornish","sequence":"first","affiliation":[{"name":"Department of Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. E.","family":"Callon","sequence":"additional","affiliation":[{"name":"Department of Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Q.-X.","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. L.","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. B.","family":"Mulvey","sequence":"additional","affiliation":[{"name":"School of Biological Sciences, University of Auckland, Auckland 1001, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. J. S.","family":"Cooper","sequence":"additional","affiliation":[{"name":"Department of Medicine and"},{"name":"School of Biological Sciences, University of Auckland, Auckland 1001, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. R.","family":"Reid","sequence":"additional","affiliation":[{"name":"Department of Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"24","reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033583500005369"},{"issue":"37","key":"B2","first-page":"E827","volume":"274","author":"Cornish J.","year":"1998","journal-title":"Am. J. Physiol."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/0309-1651(85)90015-3"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/0300-483X(94)03010-Y"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/BF02555849"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1080\/15287399009531444"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1210\/endo-126-3-1416"}],"container-title":["American Journal of Physiology-Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.physiology.org\/doi\/pdf\/10.1152\/ajpendo.1999.277.5.E779","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,8]],"date-time":"2019-09-08T13:20:49Z","timestamp":1567948849000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.physiology.org\/doi\/10.1152\/ajpendo.1999.277.5.E779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,11,1]]},"references-count":7,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1999,11,1]]}},"alternative-id":["10.1152\/ajpendo.1999.277.5.E779"],"URL":"https:\/\/doi.org\/10.1152\/ajpendo.1999.277.5.e779","relation":{},"ISSN":["0193-1849","1522-1555"],"issn-type":[{"value":"0193-1849","type":"print"},{"value":"1522-1555","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,11,1]]}}}